Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11784499 | 0.98 | APP (0.41) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL16370305 | 0.98 | APP (0.41) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL25385302 | 0.93 | APP (0.44) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL25382857 | 0.93 | APP (0.44) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL5144485 | 0.93 | APP (0.44) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL5637565 | 0.83 | APP (0.44) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL5026578 | 0.82 | — | — | |
| SCHEMBL918218 | 0.81 | APP (0.35) | APPALDH1A1EPHX2 | |
| SCHEMBL25355943 | 0.81 | APP (0.42) | APPTP53PTGS1PDE4ALMNA | |
| SCHEMBL9011748 | 0.81 | APP (0.42) | APPTP53PTGS1PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160133992-A1 | DRYING OF ELECTROLYTE MIXTURES CONTAINING ACIDS WITH MOLECULAR SIEVES | BASF SE (DE) | 2016-05-12 | — | — | US | claimed |
| WO-2015004236-A1 | DRYING OF ELECTROLYTE MIXTURES CONTAINING ACIDS WITH MOLECULAR SIEVES | BASF SE (DE) | 2015-01-15 | — | — | WO | claimed |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-03-03 | — | — | US | claimed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | claimed |
| US-10230131-B2 | Method for producing a dehydrated liquid organic carbonate mixture | Gotion Inc. (US) | 2019-03-12 | — | — | US | disclosed |
| US-20160218391-A1 | METHOD FOR PRODUCING A DEHYDRATED LIQUID ORGANIC CARBONATE MIXTURE | BASF SE (DE) | 2016-07-28 | — | — | US | disclosed |
| US-20160133992-A1 | DRYING OF ELECTROLYTE MIXTURES CONTAINING ACIDS WITH MOLECULAR SIEVES | BASF SE (DE) | 2016-05-12 | — | — | US | disclosed |
| WO-2015004233-A1 | METHOD FOR PRODUCING A DEHYDRATED LIQUID ORGANIC CARBONATE MIXTURE | BASF SE (DE) | 2015-01-15 | — | — | WO | disclosed |
| WO-2015004236-A1 | DRYING OF ELECTROLYTE MIXTURES CONTAINING ACIDS WITH MOLECULAR SIEVES | BASF SE (DE) | 2015-01-15 | — | — | WO | disclosed |
| US-7311893-B2 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-12-25 | — | — | US | disclosed |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-03-03 | — | — | US | disclosed |
| EP-1303311-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | Neurochem, Inc. (CA) | 2003-04-23 | — | — | EP | disclosed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | disclosed |
| WO-2002007781-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | NEUROCHEM INC. (CA) | 2002-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | APP 1/4885TP53 721/4885PTGS1 4215/4885 |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | APP 1/4885TP53 721/4885PTGS1 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.